FRANKFURT, Germany — The ICL allows for reliable, predictable correction of low to high degrees of myopia with similar safety and visual performance across all groups, according to a study on a large cohort.
This study provides evidence that “the ICL should not be reserved only for high degrees of myopia, and it performs extremely well across all degrees of myopia,” Milad Modabber, MD, said at the ESCRS winter meeting.
A total of 1,332 patients who received the EVO/EVO+ ICL (STAAR Surgical) between 2016 and 2023 at the Herzig Eye (Read more...)